Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: Evidence for a potential novel binding site

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 145-153

  Levant, Beth ^a   Moehlenkamp, Jeffrey D ^a   Morgan, Kimberly A ^a   Leonard, Neda L ^a   Cheng, C C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM ION; CLORGYLINE; DEBRISOQUINE; DOPAMINE 2 RECEPTOR; EDETIC ACID; ISOCARBOXAZID; MAGNESIUM ION; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; NIALAMIDE; PARGYLINE; PHENELZINE; PHENYLBIGUANIDE; POTASSIUM ION; PROPYLNORAPOMORPHINE; QUINPIROLE; SODIUM CHLORIDE; SPIPERONE; TRANYLCYPROMINE; TRITIUM; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE DERIVATIVE;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING SITE; DRUG POTENCY; ENZYME ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; SUBSTANTIA NIGRA; TEMPERATURE; VENTRAL TEGMENTUM; ANIMAL; BINDING COMPETITION; DOSE RESPONSE; DRUG EFFECT; SPRAGUE DAWLEY RAT;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CORPUS STRIATUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOLINES; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SPIPERONE;

EID: 0030302493     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6: 3177-3188, 1986.
2. 50) of an enzymatic reaction. Biochem. Pharmacol 22: 3099-3108, 1973.
3. CLARK, D. AND WHITE, F. J.: Review: D1 dopamine receptor-the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional significance. Synapse 1: 347-388, 1987.
4. 3 receptors in rat brain. Eur. J. Pharmacol. 211: 189-194, 1992.
5. ITZHAK, Y., MASH, D., ZHANG, S.-H. AND STEIN, I.: Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brains: mutual effects of monoamine oxidase inhibitors and σ ligands on MPTP and σ binding sites. Mol. Pharmacol. 39: 385-393, 1991a.
6. ITZHAK, Y., STEIN, I, ZHANg, S.-H., KASSIM, C. O. AND CRISTANTE, D.: Binding of σ-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of σ-receptor subtypes. J. Pharmacol. Exp. Ther. 257: 141-148, 1991b.
7. 3 receptors. Synapse 14: 90-95, 1993.
8. 2-like dopamine receptors in rat brain. J. Pharmacol. Exp. Ther. 262: 929-935, 1992.
9. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264: 991-1001, 1993a.
10. 3H]quinpirole binding in rat striatal membranes. Eur. J. Pharmacol. 246: 171-178, 1993b.
11. 3 receptors: Effects of ions and guanine nucleotides. J. Pharmacol. Exp. Ther. 274: 790-797, 1995.
12. 2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10: 2587-2600, 1990.
13. MUNSON, P. J. AND RODBARD, D.: LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
14. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol. 108: 597-603, 1993.
15. 3H]quinpirole. Eur. J. Pharmacol. 203:105-109, 1991.
16. THASE, M. E., TRIVEDI, M. H. AND RUSH, A. J.: MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 12: 185-219, 1995.